-
It keeps getting smarter out there, and this looks to be something that I hope moves along very quickly, so instead of waiting days or weeks for blood tests, this could be done at bedside at the hospital, or for that matter even at the office perhaps down the road. BD When you're sick, getting...
-
10 genetic mutations were found in the patient's tumor and virtually every cell in the tumor sample had nine of the mutations. “What's striking about the new research is that the scientists were able to sift through the 3 billion pairs of chemical bases that make up the human genome to...
-
According to the study, statins are lowering the PSA levels, but the concern is whether or not this could be hiding or clouding the issues and cancer could be potentially missed in the diagnosis as they are not sure if this is lowering the test numbers or if it is in fact helping in the prevention of...
-
One thing that comes to mind is what a waste of talent here. Series of events lead up to where he is today, but started when he ran out of money for his research related to the GFP gene and cancer. “Researchers worldwide now use GFP to track development of brain cells, the growth of tumors...
-
As the article states, you don’t need marketing for cancer drugs, as the need is unfortunately already there, thus marketing for cancer drugs does not necessarily carry the same sales expense as do other drugs. We have all seen the “tiered plans” on what level drugs are listed with insurance coverage...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
10-13-2008
Filed under:
Filed under: Medically Related, Insurance, Other Items of Interest, My Commentaries, personalized medicine, Genomics, health insurance, Pharma, Prescriptions, Cancer, R and D, Science 2.0
-
This is probably a good move to speed this process up since many pharmaceutical companies have and are looking at moving more trials to India. More information can be read here about the changing face of Pharma in reference to research and development. One more area to think about too is the use...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
09-19-2008
Filed under:
Filed under: Medically Related, Pharma/FDA News, Genomics, drugs, Pharma, Cancer, clinical trials, Congress, DNA Testing, National Cancer Institute, Justice Department
-
This is a very small clinical trial of 12 individuals with cancer, and any related treatment plans are still quite a few miles away, but more work with personalized medicine in progress. BD This week, University of Michigan scientists will begin a phase 1 clinical trial for the treatment...
-
If you want to do some reading up on the topic, this site may offer some help, along with the upcoming conference to be held here in the Los Angeles area in October. As posted recently there are plans for many of the service companies, such as 23andMe , Navigenics , DeCode, LabCorp , and perhaps...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
09-11-2008
Filed under:
Filed under: Medically Related, Pharma/FDA News, My Commentaries, Physician, personalized medicine, Genomics, Cancer, Pharmacogenomics, Patients, Genonimic Testing, Human Genome Project, Genomic Counseling, Lab Tests
-
Many of the generic manufacturers started years back with knock off drugs to sell locally in India, but now the game is changing to where US Pharma is using some of the talent, which costs less than R and D individuals here in the states, to further develop existing work, in other words somewhat continue...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
09-05-2008
Filed under:
Filed under: Medically Related, Pharma/FDA News, Genomics, drugs, Pharma, Biotech, Cancer, FDA, Budgets, R and D, Alzheimers, Outsourcing
-
For those of you who read the blog here and are not aware of what a "Carnival" is, it represents a collection of some of the top blogging posts in a period of time assembled in one place to review and read. Today, Highlight Health is hosting the carnival and I am delighted that...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
09-05-2008
Filed under:
Filed under: Medically Related, Technology, Genomics, healthcare, Proteins, Cancer, cancer research, Pharmacogenomics, R and D, Bloggers, Stand up to Cancer
-
This lends itself to an area whereby various area of cancer could be targeted, and with few or little side effect as the study states. The term "cellular immortality" is the term that describes cells that keep regenerating endlessly, like cancer cells do. It's a long way to...
-
This is very interesting and thanks to Medgadget for finding this one. Will we someday be listening to cancer genes and perhaps others? If you would like to hear what the genes sound like, here’s the page. I do have to say that this is a very interesting concept whereby I wonder if...